Back to search

Switzerland· 67710001

Virgan 1.5 mg/g, gel ophtalmique

A ganciclovir product containing ganciclovirum, registered in Switzerland by THEA Pharma S.A. and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC S01AD09

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedVirgan 1.5 mg/g, gel ophtalmiqueATCS01AD09REGISTER NO.67710001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Ganciclovir is registered in 9 of 19 countries.

Countries holding a registration under ATC S01AD09 (ganciclovir), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Ganciclovir · ATC S01AD09

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
ganciclovirum
Manufacturer
THEA Pharma S.A.
Country
Switzerland (CH)
ATC code
S01AD09
ATC class
Ganciclovir
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680677100017
    Tb 5 g
    CHF 28.15

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ganciclovir in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Cymevene, Ganciclovir Oresund Pharma
  • Belgium · Cymevene, Virgan
  • Bulgaria · Ганцикловир Ромфарм
  • Czechia · Cymevene, Virgan
  • Germany · Cymeven I.V., Ganciclovir Accord
  • Denmark · Cymevene, Ganciclovir Oresund Pharma
  • Spain · Cymevene, Ganciclovir Accord
  • Finland · Cymevene, Ganciclovir Bioglan
  • France · Cymevan, Ganciclovir Hikma
  • United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
  • Greece · Gancilen, Virgan
  • Croatia · Cymevene
  • Hungary · Cymevene, Ganciclovir Rompharm
  • Ireland · Cymevene
  • Italy · Citovirax, Ganciclovir Accord
  • Luxembourg · Cymevene, Virgan
  • Netherlands · Cymevene, Ganciclovir Sandoz
  • Norway · Cymevene, Ganciclovir Bioglan
  • Poland · Cymevene, Ganciclovir Accord
  • Portugal · Cymevene, Ganciclovir Accord
  • Romania · Ganciclovir Rompharm, Virgan
  • Sweden · Cymevene, Ganciclovir Bioglan
  • Slovakia · Cymevene

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/105b956c-0744-48da-a649-fe67644cecb9
GET /v1/drugs/105b956c-0744-48da-a649-fe67644cecb9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "ganciclovirum 1.5 mg",
  "valid_from": "2021-12-01",
  "limitations": null,
  "galenic_form": "Augengel 1.5 mg/g",
  "therapeutic_area": null,
  "sl_inclusion_date": "2021-12-01",
  "self_retention_pct": 10
}

See everything about ganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.